Revenue increased 14.0%
Revenue changed +14.0% from the comparable as-filed period.
$1.4B→$1.6B2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →INCY financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating income changed across a sign change
Operating income changed -259.7% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
$443.5M→-$708.4M2 prior comparisons
Inventory / revenue moved 251 bp higher
Inventory / revenue changed +251 basis points from the comparable as-filed period.
6.11%→8.62%2 prior comparisons
Operating cash flow changed across a sign change
Operating cash flow changed -220.7% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
$559.4M→-$675.3M2 prior comparisons
Working capital / assets moved 961 bp higher
Working capital / assets changed +961 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
46.43%→56.04%4 prior comparisons
Total assets increased 15.1%
Total assets changed +15.1% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$6.3B→$7.3B4 prior comparisons
Operating cash-flow margin moved 8432 bp lower
Operating cash-flow margin changed -8432 basis points from the comparable as-filed period.
40.95%→-43.37%2 prior comparisons
R&D / revenue moved 7797 bp higher
R&D / revenue changed +7797 basis points from the comparable as-filed period.
37.09%→115.06%2 prior comparisons
Gross margin moved 26 bp higher
Gross margin changed +26 basis points from the comparable as-filed period.
92.75%→93.02%2 prior comparisons
Current ratio increased 20.2%
Current ratio changed +20.2% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
3.2→3.844 prior comparisons
Selling, general & administrative increased 10.7%
Selling, general & administrative changed +10.7% from the comparable as-filed period.
$329.1M→$364.3M2 prior comparisons
Current liabilities increased 7.4%
Current liabilities changed +7.4% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$1.3B→$1.4B4 prior comparisons
Cost of revenue increased 9.8%
Cost of revenue changed +9.8% from the comparable as-filed period.
$99.0M→$108.7M2 prior comparisons
Stock-based compensation increased 13.3%
Stock-based compensation changed +13.3% from the comparable as-filed period.
$61.6M→$69.8M2 prior comparisons
SBC / revenue moved 3 bp lower
SBC / revenue changed -3 basis points from the comparable as-filed period.
4.51%→4.48%2 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.